Fedricker Diane Barber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fedricker Diane Barber has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Razelle Kurzrock
The University of Texas MD Anderson Cancer Center, Houston, TX
3 shared publicationsGiora Mavligit
Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas
2 shared publicationsAdrienne Howard
The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publicationAlex Cheung
Phase I Program, Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas
1 shared publication- Apostolia Maria Tsimberidou
The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publication Aung Naing
The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publication
Latest Publications
- 1 February 2025
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 29 (1) , 100-103
Anti–Diversity, Equity, and Inclusion Legislation: Potential Impacts on Oncology Nursing Workforce Diversity and Patient Health Outcomes
The U.S. Department of Health and Human Services posits that laws and policies are vital determinants of health and well-being (Teitelbaum et al., 2021). They contribute to the environments in which people are born, learn, live, work, worship, play, and age. Laws and policies can stimulate positive behaviors or discourage harmful behaviors; they can improve or worsen physical or mental health; and they can increase or decrease health disparities, health equity, and health literacy (Teitelbaum et al., 2021).
- 1 February 2025
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 29 (1) , 100-103
Anti–Diversity, Equity, and Inclusion Legislation: Potential Impacts on Oncology Nursing Workforce Diversity and Patient Health Outcomes
The U.S. Department of Health and Human Services posits that laws and policies are vital determinants of health and well-being (Teitelbaum et al., 2021). They contribute to the environments in which people are born, learn, live, work, worship, play, and age. Laws and policies can stimulate positive behaviors or discourage harmful behaviors; they can improve or worsen physical or mental health; and they can increase or decrease health disparities, health equity, and health literacy (Teitelbaum et al., 2021).
- Open Access
- 12 October 2022
- Published by Harborside Press, LLC in Journal of the Advanced Practitioner in Oncology
- Vol. 13 (7) , 664-672
Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center Experience
Background: Advanced practice providers (APPs) play important roles in enrolling, educating, and caring for patients in clinical trials. However, much remains unknown about the role of APPs in managing adverse events (AEs) in early (phase I to II) clinical trials. In this study, we assessed the outpatient management of grade 3 to 4 AEs by APPs in early trials and characterized the workflow of our APP Phase I to II Fast Track (FT) Clinic. Patients and Methods: We retrospectively reviewed records of patients with advanced or metastatic solid tumors enrolled in phase I to II clinical trials who were seen by APPs from September 2017 to August 2018 in the APP phase I to II FT clinic in the Department of Investigational Cancer Therapeutics. Results: A total of 808 patients enrolled in 159 clinical trials were seen in 2,697 visits (median 3 visits per patient; range 1–28) by 10 APPs. Treatment was interrupted in 6.9% of visits, and grade 3 to 4 AEs were seen in 5.4% of visits; however, patients from 1.4% of visits were sent to the emergency center (EC) and/or admitted. Patients referred to the EC and/or admitted were more likely to have baseline hypoalbuminemia, high lactate dehydrogenase, and poor Eastern Cooperative Oncology Group performance status (i.e., ECOG > 1; p < .001). There were no associations between EC referral and gender, APP years of experience, or type of treatment. Conclusions: The APP Phase I to II FT Clinic has an important role in the management of AEs by APPs in early clinical trials in the outpatient setting, potentially avoiding EC visits and admissions.
- 12 October 2022
- Published by Harborside Press, LLC in Journal of the Advanced Practitioner in Oncology
- Vol. 13 (7) , 664-672
Open AccessManagement of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center Experience
Background: Advanced practice providers (APPs) play important roles in enrolling, educating, and caring for patients in clinical trials. However, much remains unknown about the role of APPs in managing adverse events (AEs) in early (phase I to II) clinical trials. In this study, we assessed the outpatient management of grade 3 to 4 AEs by APPs in early trials and characterized the workflow of our APP Phase I to II Fast Track (FT) Clinic. Patients and Methods: We retrospectively reviewed records of patients with advanced or metastatic solid tumors enrolled in phase I to II clinical trials who were seen by APPs from September 2017 to August 2018 in the APP phase I to II FT clinic in the Department of Investigational Cancer Therapeutics. Results: A total of 808 patients enrolled in 159 clinical trials were seen in 2,697 visits (median 3 visits per patient; range 1–28) by 10 APPs. Treatment was interrupted in 6.9% of visits, and grade 3 to 4 AEs were seen in 5.4% of visits; however, patients from 1.4% of visits were sent to the emergency center (EC) and/or admitted. Patients referred to the EC and/or admitted were more likely to have baseline hypoalbuminemia, high lactate dehydrogenase, and poor Eastern Cooperative Oncology Group performance status (i.e., ECOG > 1; p < .001). There were no associations between EC referral and gender, APP years of experience, or type of treatment. Conclusions: The APP Phase I to II FT Clinic has an important role in the management of AEs by APPs in early clinical trials in the outpatient setting, potentially avoiding EC visits and admissions.
- Open Access
- 1 January 2021
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 8 (1) , 103-105
Identification and Management of Posterior Reversible Encephalopathy Syndrome in a Patient Enrolled in an Immunotherapy Combination Phase I Clinical Trial: A Case Study
- 1 January 2021
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 8 (1) , 103-105
Open AccessIdentification and Management of Posterior Reversible Encephalopathy Syndrome in a Patient Enrolled in an Immunotherapy Combination Phase I Clinical Trial: A Case Study
- 1 June 2020
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 24 (3) , 296-304
Oncology Nurse Practitioner Competencies: Defining Best Practices in the Oncology Setting
The oncology nurse practitioner (ONP) role has evolved since the first ONP competencies were published by the Oncology Nursing Society in 2007. An update was completed in 2019 to reflect the rapidly expanding role. The purpose of this article is to describe the process of the ONP competency development and identify potential applications across a variety of oncology settings. The team performed an extensive literature review of the research about ONP practice across the cancer care continuum. Peer and expert review were conducted to ensure the competencies were comprehensive and relevant. The ONP competencies provide a solid, evidence-based benchmark to standardize the ONP role and practice, thereby ensuring that patients receive the highest-quality cancer care.
- 1 June 2020
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 24 (3) , 296-304
Oncology Nurse Practitioner Competencies: Defining Best Practices in the Oncology Setting
The oncology nurse practitioner (ONP) role has evolved since the first ONP competencies were published by the Oncology Nursing Society in 2007. An update was completed in 2019 to reflect the rapidly expanding role. The purpose of this article is to describe the process of the ONP competency development and identify potential applications across a variety of oncology settings. The team performed an extensive literature review of the research about ONP practice across the cancer care continuum. Peer and expert review were conducted to ensure the competencies were comprehensive and relevant. The ONP competencies provide a solid, evidence-based benchmark to standardize the ONP role and practice, thereby ensuring that patients receive the highest-quality cancer care.
- 1 February 2020
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 24 (1) , 81-87
Advance Care Planning: Advanced Practice Provider–Initiated Discussions and Their Effects on Patient-Centered End-of-Life Care
Advance care planning (ACP) is an ongoing process of communication involving patients, family members, and caregivers on one side and healthcare providers on the other to establish values, goals, and preferences for future care, along with discussions concerning end-of-life care options. Advance directives promote patient autonomy and provide written documentation of a patient's wishes for future care. This quality improvement project aimed to determine if ACP discussions initiated by an advanced practice provider (APP) would enhance patient-centered end-of-life care. This study involved retrospective data collection of 20 inpatients and 20 outpatients without a scanned advance directive in the electronic health record at the time of admission or clinic visit, as well as an ACP intervention by an APP. APPs can initiate ACP discussions with patients with cancer, which may assist in their understanding of ACP, resulting in completion of the advance directive documents and a change in their code (resuscitation) status.
- 1 February 2020
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 24 (1) , 81-87
Advance Care Planning: Advanced Practice Provider–Initiated Discussions and Their Effects on Patient-Centered End-of-Life Care
Advance care planning (ACP) is an ongoing process of communication involving patients, family members, and caregivers on one side and healthcare providers on the other to establish values, goals, and preferences for future care, along with discussions concerning end-of-life care options. Advance directives promote patient autonomy and provide written documentation of a patient's wishes for future care. This quality improvement project aimed to determine if ACP discussions initiated by an advanced practice provider (APP) would enhance patient-centered end-of-life care. This study involved retrospective data collection of 20 inpatients and 20 outpatients without a scanned advance directive in the electronic health record at the time of admission or clinic visit, as well as an ACP intervention by an APP. APPs can initiate ACP discussions with patients with cancer, which may assist in their understanding of ACP, resulting in completion of the advance directive documents and a change in their code (resuscitation) status.
- Open Access
- 1 July 2019
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 6 (3) , 212-226
Adverse Events of Oncologic Immunotherapy and Their Management
- 1 July 2019
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 6 (3) , 212-226
Open AccessAdverse Events of Oncologic Immunotherapy and Their Management
- 1 April 2018
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 14 (4) , 259-266
Recent Developments in Oncology Immunotherapy, Adverse Effects Part 2
- 1 April 2018
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 14 (4) , 259-266
Recent Developments in Oncology Immunotherapy, Adverse Effects Part 2
- 10 February 2017
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 13 (5) , 328-335
Multiple Myeloma: The Role of the Primary Care Nurse Practitioner
- 10 February 2017
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 13 (5) , 328-335
Multiple Myeloma: The Role of the Primary Care Nurse Practitioner
- 1 June 2016
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 20 (3) , 334-335
Improving the Education and Training of Primary Care Nurse Practitioners to Meet the Healthcare Needs of Long-Term Cancer Survivors
The United States has a well-documented shortage of primary care providers (PCPs) and oncologists. Cancer survivors are living longer because of advances in treatment, and, consequently, more are seeking survivorship care from PCPs; this trend is predicted to continue. One proposed solution is to increase the use of nurse practitioners (NPs). However, most NP programs do not provide adequate training or education that is specific to the needs of long-term cancer survivors. .
- 1 June 2016
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 20 (3) , 334-335
Improving the Education and Training of Primary Care Nurse Practitioners to Meet the Healthcare Needs of Long-Term Cancer Survivors
The United States has a well-documented shortage of primary care providers (PCPs) and oncologists. Cancer survivors are living longer because of advances in treatment, and, consequently, more are seeking survivorship care from PCPs; this trend is predicted to continue. One proposed solution is to increase the use of nurse practitioners (NPs). However, most NP programs do not provide adequate training or education that is specific to the needs of long-term cancer survivors. .
- 29 August 2013
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 40 (5) , 481-9
Effects of Social Support on Physical Activity, Self-Efficacy, and Quality of Life in Adult Cancer Survivors and Their Caregivers
To explore the relationships between adult cancer survivor and caregiver social support, self-efficacy for physical activity (SEPA), physical activity (PA) behavior, and quality of life (QOL); and to understand cancer survivors' and their caregivers' perceptions of social support in PA participation. Quasi-experimental. Five community-based exercise sites located in East Texas. 101 adult cancer survivors and caregivers. Participants completed questionnaires, the 8-Foot Up-and-Go test, and open-ended questions. Data analysis included descriptive statistics and frequencies, Spearman's rho, Mann-Whitney U, and Wilcoxon signed-rank test. Qualitative data were analyzed using thematic analysis. Social support, SEPA, PA, and QOL. Physical QOL was significantly higher in caregivers than cancer survivors. Spearman's rho identified a negative relationship between physical QOL and PA in cancer survivors; and a significant relationship between PA and PA participation in caregivers with social support from friend. Three themes emerged from the qualitative data regarding the perception of social support: companionship, motivation, and health promotion. Caregivers have higher QOL despite being the major social support provider to cancer survivors. Social support is essential to PA participation. Interventions to increase PA in adult cancer survivors may consider encouraging their caregivers to actively participate. Caregivers play an important role in the PA of cancer survivors. Perceived social support in the form of companionship and motivation may increase PA in cancer survivors and caregivers. Therefore, nurses may consider educating cancer survivors and caregivers on the importance of adopting and maintaining PA throughout the cancer care continuum.
- 29 August 2013
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 40 (5) , 481-9
Effects of Social Support on Physical Activity, Self-Efficacy, and Quality of Life in Adult Cancer Survivors and Their Caregivers
To explore the relationships between adult cancer survivor and caregiver social support, self-efficacy for physical activity (SEPA), physical activity (PA) behavior, and quality of life (QOL); and to understand cancer survivors' and their caregivers' perceptions of social support in PA participation. Quasi-experimental. Five community-based exercise sites located in East Texas. 101 adult cancer survivors and caregivers. Participants completed questionnaires, the 8-Foot Up-and-Go test, and open-ended questions. Data analysis included descriptive statistics and frequencies, Spearman's rho, Mann-Whitney U, and Wilcoxon signed-rank test. Qualitative data were analyzed using thematic analysis. Social support, SEPA, PA, and QOL. Physical QOL was significantly higher in caregivers than cancer survivors. Spearman's rho identified a negative relationship between physical QOL and PA in cancer survivors; and a significant relationship between PA and PA participation in caregivers with social support from friend. Three themes emerged from the qualitative data regarding the perception of social support: companionship, motivation, and health promotion. Caregivers have higher QOL despite being the major social support provider to cancer survivors. Social support is essential to PA participation. Interventions to increase PA in adult cancer survivors may consider encouraging their caregivers to actively participate. Caregivers play an important role in the PA of cancer survivors. Perceived social support in the form of companionship and motivation may increase PA in cancer survivors and caregivers. Therefore, nurses may consider educating cancer survivors and caregivers on the importance of adopting and maintaining PA throughout the cancer care continuum.